Fellowship · Chicago, IL
Sponsored by McGaw Medical Center of Northwestern University · Director Leena Mithal
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
The New England journal of medicine · 2022 · 868 citations · William Muller
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
The New England journal of medicine · 2023 · 422 citations · Caroline Reuter
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
JAMA · 2022 · 529 citations · Kathryn Edwards
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
The Lancet. Child & adolescent health · 2023 · 248 citations · William Muller
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
The New England journal of medicine · 2023 · 218 citations · William Muller
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024 · 189 citations · Kathryn Edwards, William Muller
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
JAMA · 2021 · 454 citations · Kathryn Edwards
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.
Science (New York, N.Y.) · 2025 · 66 citations · Caroline Reuter